Adverse effects of ARBs

1 Do no increase BRADYKININ Levels 2 May be used as first-line agents for HTN, esp in patients with a compelling indication of DM,HF, or CKD. 3 Similar effects as ACEIn, although the risks of cough and angioedema are significantly decreased.